INPP5E Knockout HAP1 Cell Line
Cat.No.:
EDC08129
Species:
Human
Cell Name:
HAP1
Gene:
INPP5E
Gene ID:
56623
Size:
1×10⁶cells
INPP5E Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08129 |
|---|---|
| Product Name | INPP5E Knockout HAP1 Cell Line |
| Species | Human |
| Cell Line | HAP1 |
| Cellosaurus ID | CVCL_0F62 |
| Gene ID | |
| Cell Line Synonyms | Highly Aggressively Proliferating Immortalized |
| Gene | INPP5E |
| Summary |
The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | IMDM+10%FBS |
| Freezing Medium | 90%FBS+10%DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Which is better for studying INPP5E function, INPP5E Knockout HAP1 Cell Line or INPP5E overexpression HAP1 Cell Line?
The choice depends on whether you are studying INPP5E (inositol polyphosphate-5-phosphatase E)'s role as a ciliary phosphoinositide phosphatase or modeling Joubert syndrome and MORM syndrome. The Knockout line is the standard tool for asking whether INPP5E is required for these processes — INPP5E is a phosphoinositide 5-phosphatase that hydrolyzes PI(4,5)P2 to PI(4)P and PI(3,4,5)P3 to PI(3,4)P2; INPP5E is uniquely localized to the primary cilium membrane via prenylation, where it maintains the ciliary phosphoinositide composition (low PI(4,5)P2, high PI(4)P). Overexpression is useful for studying INPP5E in heterologous expression contexts.
For ciliopathy research, the EDITGENE INPP5E Knockout in HAP1 is highly informative — INPP5E mutations cause Joubert syndrome type 1 (JBTS1, cerebellar vermis hypoplasia, retinal dystrophy) and MORM syndrome (mental retardation, truncal obesity, retinal dystrophy, micropenis). Rescue with wild-type or phosphatase-dead INPP5E enables disease genotype-function studies. The knockout is valuable for studying ciliary phosphoinositide biology, Hedgehog signaling (ciliary phosphoinositides regulate Hedgehog pathway), and emerging Joubert syndrome therapeutic strategies.
What are the application scenarios for this model?
Primary applications:
• Ciliary phosphoinositide composition: PI(4,5)P2 and PI(4)P imaging in primary cilia using phosphoinositide-specific biosensors (TUBBY-PH, GFP-2xPH-PLCδ).
• Hedgehog signaling: SMO ciliary localization and GLI target gene (PTCH1, GLI1) expression analysis following SHH stimulation given ciliary phosphoinositide regulation of Hedgehog pathway.
• Joubert syndrome modeling: rescue with patient-derived INPP5E mutations for genotype-function studies of cerebellar vermis hypoplasia ciliopathy.
• Ciliary biology: cilium length, frequency, and trafficking analysis given INPP5E's ciliary localization.
EDITGENE recommends this model for researchers investigating ciliary phosphoinositide biology, Joubert syndrome mechanisms, and Hedgehog pathway-ciliopathy interactions.
Is this INPP5E Knockout HAP1 Cell Line compatible with overexpression rescue experiments?
Yes. INPP5E rescue experiments require attention to ciliary targeting:
• Construct design: use a codon-modified INPP5E sequence with a small N-terminal tag (FLAG, HA) — INPP5E has C-terminal CaaX prenylation motif (farnesylation) for membrane attachment, so C-terminal tags will disrupt prenylation and ciliary localization.
• Ciliary localization validation: confirm primary cilium localization by co-staining with cilium markers (acetylated tubulin, ARL13B) before functional assays.
• Phosphatase-dead rescue: catalytic residue mutations in the phosphatase domain abolish PI(4,5)P2 hydrolysis and serve as the standard specificity control.
• Joubert mutation rescue: patient-derived INPP5E mutations enable disease genotype-function studies of ciliopathy.
• Functional readout: rescue should restore ciliary PI(4,5)P2 hydrolysis and SHH-induced Hedgehog pathway activation.
HAP1-specific considerations:
• Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay.
• Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended.
• Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download